These compounds are often obtained through unregulated sources that lack quality control
Beyond-Use Date Up to 90 days 503B Outsourcing Facilities FDA-Registered About Produce medications in batches for broader healthcare use
Funding The author(s) declare that no financial support was received for the research and/or publication of this article
While some mild cases may resolve on their own, persistent nerve compression can cause irreversible changes to muscle function and sensation
Effects of -adrenergic antagonists on chemoradiation therapy for locally advanced non-small cell lung cancer
A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent selected from a JNK inhibitor, a TRPV modulator, a MET channel inhibitor, and an otoprotectant to the individual in need thereof, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
